Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric D Bateman

Showing results (21-30 of 161) with videos related to

Pageof 17
Sort By:
Applied Health Economics and Health Policy|January 1, 2016
Comment on: "Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists"Carl Samuelsen, Eric D Bateman, Ian Pavord, et al.
The Lancet. Respiratory Medicine|August 10, 2015
The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases?Eric D Bateman, Helen K Reddel, Richard N van Zyl-Smit, et al.
Applied Health Economics and Health Policy|June 30, 2014
Cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonistsJenny Willson, Eric D Bateman, Ian Pavord, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 19, 2021
A Practical Guide to Implementing SMART in Asthma ManagementHelen K Reddel, Eric D Bateman, Michael Schatz, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 9, 2013
Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United KingdomYevgeniy Samyshkin, Robert W Kotchie, Ann-Christin Mörk, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2011
Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthmaEric D Bateman, Oliver Kornmann, Peter Schmidt, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
QVA149 Improves Lung Function, Dyspnea, and Health Status Independent of Previously Prescribed Medications and COPD Severity: A Subgroup Analysis from the SHINE and ILLUMINATE StudiesKenneth R Chapman, Eric D Bateman, Hungta Chen, et al.
Respiratory Medicine|April 24, 2007
A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthmaLouis-Philippe Boulet, Eric D Bateman, Robert Voves, et al.
Lancet (London, England)|August 16, 2005
Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trialKlaus F Rabe, Eric D Bateman, Denis O'Donnell, et al.
COPD|October 25, 2013
Comparing dynamic hyperinflation and associated dyspnea induced by metronome-paced tachypnea versus incremental exerciseGregory L Calligaro, Richard I Raine, Mary E Bateman, et al.
Pageof 17

Showing results (21-30 of 161) with videos related to

Sort By:
Pageof 17
Applied Health Economics and Health Policy|January 1, 2016
Comment on: "Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists"Carl Samuelsen, Eric D Bateman, Ian Pavord, et al.
The Lancet. Respiratory Medicine|August 10, 2015
The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases?Eric D Bateman, Helen K Reddel, Richard N van Zyl-Smit, et al.
Applied Health Economics and Health Policy|June 30, 2014
Cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonistsJenny Willson, Eric D Bateman, Ian Pavord, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 19, 2021
A Practical Guide to Implementing SMART in Asthma ManagementHelen K Reddel, Eric D Bateman, Michael Schatz, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 9, 2013
Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United KingdomYevgeniy Samyshkin, Robert W Kotchie, Ann-Christin Mörk, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2011
Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthmaEric D Bateman, Oliver Kornmann, Peter Schmidt, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
QVA149 Improves Lung Function, Dyspnea, and Health Status Independent of Previously Prescribed Medications and COPD Severity: A Subgroup Analysis from the SHINE and ILLUMINATE StudiesKenneth R Chapman, Eric D Bateman, Hungta Chen, et al.
Respiratory Medicine|April 24, 2007
A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthmaLouis-Philippe Boulet, Eric D Bateman, Robert Voves, et al.
Lancet (London, England)|August 16, 2005
Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trialKlaus F Rabe, Eric D Bateman, Denis O'Donnell, et al.
COPD|October 25, 2013
Comparing dynamic hyperinflation and associated dyspnea induced by metronome-paced tachypnea versus incremental exerciseGregory L Calligaro, Richard I Raine, Mary E Bateman, et al.
Pageof 17